Abnormality | Report Type | Region | Study Type | Indication for CZP Use |
---|---|---|---|---|
Left sided vesico-ureteric reflux | Prospective | Africa | Open-label extension | CD |
Club foot | Prospective | North America | Noninterventional study | CD |
22Q11.2 deletion syndrome, unilateral right kidney, hypospadias, and inguinal hernia | Prospective | North America | Clinical trial | CD |
Pyloric stenosis | Prospective | North America | Clinical trial | CD |
Posterior ankyloglossia | Prospective | North America | Spontaneous | CD |
Polydactyl, left hand, pinky side | Prospective | North America | Spontaneous | RA |
Renal cyst, no treatment required | Prospective | North America | Clinical trial | RA |
Anal fistula | Prospective | Europe | Spontaneous | RA |
Cleft palate | Retrospective | North America | Spontaneous | CD |
Congenital diaphragmatic hernia | Retrospective | North America | Spontaneous | CD |
Congenital morbus hirschsprung and club feet | Retrospective | Europe | Spontaneous | RA |
Right aortic arch with aberrant left subclavian | Retrospective | Europe | Spontaneous | RA |
CZP: certolizumab pegol; CD: Crohn disease; RA: rheumatoid arthritis.